Pharmaceutical blister lidding foil specifications: what the CoA, sealing trial, and stability study each prove
Pharmaceutical blister lidding foil specifications: what the CoA, sealing trial, and stability study each prove

Pharmaceutical blister lidding foil specifications should identify the opening route, layer order, forming web, aluminum substrate, heat-seal lacquer, print, roll geometry, test methods, change-control rules, and batch documents. A CoA reports agreed fields for one material batch. A sealing trial finds a process window for the tested foil, forming web, machine, and tooling. Finished-pack tests examine seals, leaks, and opening behavior. The proposed shelf life must be supported by the drug-product stability program for the proposed container-closure system.
Prepared by Qixin Packaging for packaging, quality, validation, procurement, and contract-packing teams that need a traceable technical record from RFQ through line release.
Quick answer:
Do not ask the CoA to prove the finished blister. Do not ask a short line trial to prove shelf life. First sign the material and roll specification. Then establish the sealing window and inspect the finished pack with applicable strength, integrity, and opening methods. The drug product owner must evaluate the complete container-closure system in the stability and regulatory program.
Four evidence levels in pharmaceutical blister lidding foil specifications
A packaging file often fails because four different records are described as proof of the same thing. They are connected, but none can replace the next level. Write each approval question beside the record that can answer it, and leave an unanswered question open.
| Evidence | Question it can answer | What it may support | What it does not prove by itself |
|---|---|---|---|
| Signed specification and batch CoA | Was the delivered material reported against the agreed fields and methods? | Identity, dimensions, named coating or print fields, roll data, and listed batch results. | The seal on the buyer’s line, leak-free cavities, patient opening, compatibility, or shelf life. |
| Packaging-line sealing trial | Can this foil and forming web run in a controlled window on this machine and tooling? | A temperature, pressure, dwell, speed, and material window for the tested configuration. | Every line, every forming web, future coating changes, distribution exposure, or drug stability. |
| Finished-pack strength, integrity, and opening evaluation | Does the sealed blister meet the program’s package and use requirements? | Seal separation behavior, failure mode, selected leak evidence, opening route, and defect response. | Chemical stability of the medicine or transferability to another pack design. |
| Drug-product stability study and market dossier | Is the complete proposed container-closure system suitable for this drug and shelf life? | Product-specific stability in the proposed market pack under the approved protocol. | A blanket claim for other medicines, forming webs, opening routes, suppliers, or markets. |
FDA guidance states that a packaging system accepted for one drug is not automatically appropriate for another. ICH Q1A(R2) places drug-product stability work in the proposed marketing container-closure system. Those two boundaries prevent a material result from being stretched into a product claim.
Name the web and the opening route before discussing thickness
Blister foil is too broad for a purchase specification. A blister combines a formed cavity web with a lidding web. Either side may contain aluminum, but the materials do different jobs and are processed differently.
| Term | What it identifies | Specification consequence |
|---|---|---|
| Lidding foil | The closing web sealed over the formed cavities. | Define opening route, aluminum, coatings, print, seal side, and roll format. |
| Thermoforming web | A polymer web heated and formed into cavities. | Name the exact seal surface because the HSL must match it. |
| Cold-form Alu-Alu web | A multilayer aluminum-containing laminate cold-formed into cavities. | Do not substitute thin lidding-foil values for the forming laminate. |
| Push-through | The dosage form ruptures the lidding during opening. | Temper, thickness, scoring if used, seal land, and rupture behavior interact. |
| Peelable or peel-push | The user peels the lid, or peels one layer before pushing through another. | Upper opening-force control and whole-pack use may matter as much as minimum seal strength. |
| Strip pack | Two webs sealed around the dosage form without a preformed blister cavity. | Its sealing geometry and opening evidence should not be borrowed from a formed blister. |
Why published foil thickness ranges disagree
Public thickness figures often describe different webs, opening routes, or supplier portfolios. They are useful comparison points, but they are not interchangeable purchasing limits.
| Published example | Published aluminum thickness | What the figure describes | What still has to be specified |
|---|---|---|---|
| Amcor blister lid foil reference | Typically 12-25 microns | A general lidding-foil range across blister applications. | Opening route, temper, HSL, forming-web seal surface, print and test limits. |
| ACG Alumlid push-through portfolio | 20, 25, 30, 35, 37 and 40 microns | Current thickness options published for one supplier’s push-through lidding family. | Which primer/HSL route applies, the buyer’s opening target and the validated line window. |
| Amcor strip-pack foil reference | 20-50 microns, soft temper | Foil used in a two-web strip pack around the dosage form. | Do not transfer this range to a formed blister lidding specification. |
| Amcor cold-form aluminum reference | 45-60 microns, soft temper | The aluminum reference for a cold-form cavity web, not thin lidding foil. | The complete forming laminate, cavity design, lidding partner and forming validation. |
Amcor and ACG also publish materially different push-through, peelable, peel-push, and cut-open structures. Put the opening route at the start of the specification. Adding it after foil selection is too late because the route changes the construction and test plan.
Read OP / Printing / AL / VC lacquer as a question list
A shorthand layer line is useful for orientation. It is not enough for release. ACG publishes a common print primer / aluminum / HSL lidding structure and separate HSL routes for different forming-web surfaces. Qixin’s current product listing uses OP/Printing/AL/VC Lacquer. Before trial, each abbreviation needs a side, function, identity, and test field.
| Layer or field | Job in the construction | Define in the signed file | Failure when vague |
|---|---|---|---|
| OP / primer | Supports or protects the outside print/surface under the selected route. | Exact function, coat side, chemistry or grade reference, application weight where controlled, cure, test. | Ink rub, blocking, poor adhesion, or a document describing the wrong coating. |
| Print / ink | Carries brand and required artwork on the defined side. | Artwork revision, colors, repeat, eye mark, registration, print side, cure, rub/set-off method. | Registration drift, unreadable data zone, ink transfer, wrong winding direction. |
| AL substrate | Carries the lidding structure and affects barrier, rupture, handling, and winding behavior. | Alloy, temper, nominal thickness, tolerance method, surface, defects or pinhole method where required. | Foil splits, poor push-through, wrinkles, or comparisons between base foil and finished laminate. |
| HSL / VC lacquer | Bonds the lidding to the named forming-web seal surface. | Seal side, compatible forming web, material reference, application weight where controlled, release method, storage. | No seal, narrow window, overbonding, channels, blocking, or transfer to the wrong surface. |
Minimum reproducible pharmaceutical blister lidding foil specifications
Write one controlled line for the material and another for the roll. A foil can pass chemistry and thickness checks but still be unusable because the coating side, winding direction, core, splice, or print repeat does not fit the line.
| Specification block | Fields to sign | Release evidence |
|---|---|---|
| Package identity | Dosage-form project, forming web, opening route, lidding construction revision. | Approved specification and change-control reference. |
| Aluminum | Alloy, temper, nominal thickness, tolerances, surface and named defect checks. | CoA fields plus receiving verification at the agreed frequency. |
| Coatings | Outer coating/primer and HSL identity, side, application field, cure and storage. | Batch-linked supplier results and line/pack confirmation. |
| Artwork code, colors, repeat, eye mark, registration, unprinted zones and print side. | Approved proof or standard, inspection record, rub/set-off evidence where specified. | |
| Roll geometry | Width/tolerance, core ID and material, OD or net weight/length rule, winding direction. | Receiving measurements and roll-label reconciliation. |
| Winding quality | Edge alignment, telescoping, wrinkles, blocking, splice number/location/marking, roll hardness if controlled. | Unopened-roll condition, line feed, and retained defect evidence. |
| Packing and traceability | Roll ID, batch, manufacture/retest date if used, protection, pallet layout, storage and transport controls. | Label, packing list, CoA link, damage and receipt record. |
| Documents and changes | Required declarations, test reports, CoA content, retention period, change-notification fields. | Approved document set and change assessment, not a generic certificate folder. |
Qixin’s current blister-foil listing gives quote-starting fields of 0.018-0.036 mm thickness, 60-700 mm width, 8011/8079 hard or soft routes, and an OP/Printing/AL/VC-lacquer shorthand. Those values help open a discussion. The signed project specification must narrow the applicable construction, tolerances, methods, documents, and line conditions.
What the CoA proves in pharmaceutical blister lidding foil specifications
A CoA is a batch-linked report. Its authority comes from the specification, sampling plan, and method named beside each result. If coating identity, coat weight, print registration, or a defect check is absent, the CoA does not silently prove it.
Within pharmaceutical blister lidding foil specifications, decide which batch results are needed for release, which fields are checked at receiving, and which performance questions remain with the packaging line or drug-product program.
Build the CoA from the release decision
Start with identity: supplier, material code and revision, batch, roll range, manufacture date, and the specification version used for release. Then list the fields the buyer actually needs to trend or release. Typical project fields may include thickness, width, alloy/temper identity, coating reference or application result, print or color controls, and named physical tests. The exact list is contractual, not universal.
For each result, keep the unit, method, acceptance criterion, result, sampling basis, status, and authorized release. A statement such as conforms is hard to investigate if the method or criterion is missing. When a supplier uses an internal method, the technical agreement should identify the revision and any correlation work expected against the buyer’s method.
CoA boundary: The report can show that the supplier released a batch against listed fields. It cannot show that an unlisted test was run, that the foil sealed on the buyer’s equipment, or that the finished medicine remains within specification through shelf life.
Turn pharmaceutical blister lidding foil specifications into a sealing window
Heat-seal lacquer is selected against a forming-web seal surface. The observed seal also depends on the actual jaw temperature, pressure, dwell, line speed, seal-land geometry, tooling condition, web tension, contamination, and conditioning. A temperature copied from a data sheet is a starting hypothesis, not a validated operating window.
The sealing study translates pharmaceutical blister lidding foil specifications into controlled line evidence. It should preserve the exact material identities and record both machine setpoints and actual process readings.
Seven steps for a controlled sealing-window study
- Freeze the material identities. Record lidding revision and batch, forming-web structure and batch, coating sides, storage, conditioning, and any printed or unprinted test area.
- Record the equipment state. Identify machine, sealing station, tooling, seal-land geometry, jaw surface, temperature verification, pressure measurement, line speed, and recent maintenance.
- Define the study matrix. Select controlled temperature, pressure, dwell or speed points that cover the proposed operating region without changing several unrecorded variables together.
- Make traceable specimens. Mark each run, allow the defined stabilization period, record actual readings, retain representative sealed packs, and note cavities affected by starts or stops.
- Measure separate outputs. Record seal strength and failure mode, applicable integrity observations, visual seal continuity, foil damage, opening behavior, and print or coating effects.
- Challenge the provisional window. Repeat near the proposed edges with normal material variation, justified line speeds, tooling positions, and defined disturbances rather than testing only the center point.
- Approve and control the window. Set operating targets and action limits from the program data, identify monitoring and sampling, archive the report, and link future material or process changes to reassessment.
Copyable sealing-window record
| Record block | Fields | Why it matters |
|---|---|---|
| Materials | Lidding/formation codes, revisions, batches, sides, conditioning, storage history. | Stops a result migrating to another HSL or seal surface. |
| Machine/tooling | Machine/station, jaw and plate IDs, seal land, cavity position, maintenance state. | Separates material effects from tooling and position effects. |
| Inputs | Set and actual temperature, pressure, dwell, speed, web tension where controlled. | A displayed setpoint may not equal the condition at the seal. |
| Specimens | Run ID, time, stabilization, cavity map, sample count, conditioning and test delay. | Makes failures traceable to position and time. |
| Seal output | Method, specimen width/orientation, fixture, peak/average result as used, failure mode. | Prevents numbers from unlike test setups being compared. |
| Pack output | Visual continuity, channels/leaks by applicable method, lidding damage, opening route, print/coating condition. | Keeps strong seal, intact pack, and usable opening as separate outcomes. |
| Decision | Pass/restrict/fail, provisional edges, target, action limits, monitoring, retained samples, approvers. | Turns trial data into a controlled production instruction. |
Seal strength, leak evidence, and opening behavior answer different questions
ASTM F88/F88M treats seal strength as a quantitative measurement for process validation, capability, and control. It also notes that an upper limit can matter for packages intended to peel. The measured force depends on specimen and fixture details, and it does not simulate a user opening an entire pack.
| Question | Evidence route | Critical record | Boundary |
|---|---|---|---|
| How much force separates the sampled seal? | Defined seal-strength method such as ASTM F88/F88M when applicable. | Specimen geometry, orientation, grip/fixture, rate, conditioning, peak/average use and failure mode. | Not a whole-pack opening or leak result. |
| Is there a channel or gross leak by the selected method? | Applicable package-integrity method, justified for pack geometry and defect size. | Method/version, sensitivity or known limitation, pressure/contact route, sample map and result. | One method does not quantify every leak or prove shelf life. |
| Can the intended user open the pack correctly? | Opening-route and user evaluation appropriate to the product and market. | Pack design, user population, instructions, failure route and complete opening observations. | Cannot be inferred from thickness or peak seal force alone. |
ASTM F3039 is a destructive qualitative dye-penetration method for certain nonporous packages and does not quantify leak size. ASTM F2096 is a gross-leak bubble method. Naming the method prevents a phrase such as leak test passed from hiding sensitivity and applicability.
Use the defect pattern before changing the foil
Keep failed packs, roll labels, cavity position, line settings, and samples from before and after the event. A change made without that evidence can move the symptom while preserving the cause.
Seal and foil faults
| Observed failure | First distinction | Material route to check | Machine or handling route to check | Next evidence |
|---|---|---|---|---|
| Weak or intermittent seal | Across the web, one lane, one cavity, or start/stop only? | HSL identity/coat side, forming-web seal surface, coating application, contamination, storage. | Temperature uniformity, pressure, dwell, seal land, web tension, stabilization. | Cavity map, retained rolls/web, actual readings, seal strength and failure mode. |
| Overbonding or difficult peel | High force, erratic force, tearing, or wrong opening route? | HSL/forming-web combination, coating variation, lidding construction. | Excess heat/pressure/dwell, wide seal land, tooling condition. | Force curve/failure mode and whole-pack opening observation, not peak force alone. |
| Channel or unsealed path | Visible wrinkle, particulate path, formed-web distortion, or hidden discontinuity? | Wrinkle tendency, coating continuity, contamination, thickness variation. | Product in seal land, forming/cutting alignment, tooling damage, pressure distribution. | Applicable leak/location method, microscopy/photo, cavity and tooling map. |
| Foil split or rupture outside opening | At edge, eye mark, seal land, draw corner, guide, or patient push point? | Temper/thickness, defects, slitting edge, coating/print stress, handling damage. | Tension spike, misalignment, sharp guide, excessive seal load, tooling contact. | Failure location map, edge sample, roll position and line-event record. |
Print and roll faults
| Observed failure | First distinction | Material route to check | Machine or handling route to check | Next evidence |
|---|---|---|---|---|
| Ink rub, set-off, or transfer | In roll, at unwind, under guide, at seal, or after pack handling? | Ink/OP identity, cure, coating side, blocking, retained solvents where controlled. | Roll pressure, storage heat, guide abrasion, wrong winding, hot tooling contact. | Facing surfaces, rub/set-off method, roll-depth map, storage and line history. |
| Blocking at unwind | Coating-to-coating, ink-to-coating, isolated roll depth, or storage-related? | Cure, coating formulation/application, surface condition, winding face. | Winding pressure, storage temperature, pallet load, long dwell in stock. | Unopened roll photos, peel/unwind trend by diameter, facing-surface inspection. |
| Telescoping or edge weave | Present at receipt, after conditioning, or created on unwind? | Roll build, edge profile, splice, core fit, winding quality. | Transport impact, pallet orientation, chuck/core fit, brake/tension control. | Receipt condition, OD/core/edge measurements, pallet and line photos. |
| Print registration drift | Constant offset, periodic drift, roll-depth change, one lane, or speed-dependent? | Print repeat, eye mark, slitting, web stretch or roll build. | Sensor setup, web tension, roller slip, indexing, speed transition. | Repeat measurements, sensor trace, roll-depth map, approved artwork/eye-mark reference. |
Receiving and line-release record for each roll lot
Inspect the protected roll before removing evidence. Record pallet damage, wrap condition, core support, and telescoping before correcting them. Then reconcile the roll ID to the CoA and specification revision.
| Check | Record | Do not confuse it with |
|---|---|---|
| Identity | PO, material/revision, supplier batch, roll IDs, CoA, manufacture date if supplied. | A certificate for the same generic product name. |
| Pack and handling | Pallet, barrier wrap, desiccant if specified, impact, moisture, core support, storage condition. | Material manufacture quality. |
| Geometry | Width, core ID, OD/net weight as specified, edge alignment, telescoping. | The nominal label values without measurement. |
| Side and winding | Print face, HSL face, unwind direction, artwork orientation and eye-mark side. | A roll that can be flipped without changing print or seal orientation. |
| Surface | Wrinkles, scratches, contamination, blocking, odor where specified, ink rub/set-off. | Barrier or compliance proof. |
| Splices | Allowed count, location or roll-depth record, marking, tape route and line handling. | An unmarked web defect. |
| Line release | Machine, forming-web batch, approved window, setup result, first-off cavity map and approver. | Receiving release based only on the CoA. |
For deeper reconciliation of net foil, core, length, and diameter, use the separate aluminum foil roll weight and length cross-check. Use those calculations to reconcile roll quantity and geometry; they do not replace lidding evidence or line release.
Stability belongs to the medicine in the proposed pack
ICH Q1A(R2) states that stability testing for the dosage form should use the proposed marketing container-closure system. The resulting stability information supports the product’s acceptance criteria and proposed shelf life. The foil batch is one controlled component inside that system.
FDA guidance reaches the same practical boundary from another direction: suitability must be shown for each proposed system and intended use. A foil that worked with one tablet, cavity web, coating, and market pack is not automatically suitable for another medicine.
What the material file should hand to the stability program
Link the stability batches to the lidding specification revision, supplier and site, material batch and roll IDs, forming-web revision and batch, print/coating route, line and tooling, approved sealing window, and finished-pack release results. Preserve retained material and pack samples under the program’s rules. When a later complaint appears, the team can trace the result to a real package configuration instead of a generic phrase such as 25 micron pharma foil.
Regulatory boundary: ISO 15378 addresses a quality-management and GMP framework for primary packaging-material suppliers. It does not approve the finished blister or replace the drug product owner’s compatibility, validation, stability, and market-submission work.
Changes that should trigger a documented assessment
A visually similar roll is not evidence of equivalence. Define notification and assessment fields before supply begins, while both parties still agree what same material means.
| Change | Why it matters | Possible reassessment |
|---|---|---|
| Aluminum alloy, temper, thickness, source, or foil-making site | Can affect handling, rupture, defects, and process response. | Material comparability, line window, opening and pack evidence. |
| HSL, OP, primer, ink, solvent, application or cure | Can alter sealing, blocking, transfer, print resistance and suitability evidence. | Document review, material tests, sealing window, integrity, stability impact. |
| Forming-web structure or seal surface | The HSL bonds to that surface, not to the product name. | Full seal-system comparison and product-program impact. |
| Print layout, eye mark, repeat, code zone, or winding direction | Can affect registration, readability, line sensing and correct pack orientation. | Artwork approval, machine trial and line clearance controls. |
| Machine, sealing tooling, cavity layout, speed, or monitoring method | Can move pressure, dwell, temperature distribution, and defect detection. | Process validation or verification under the buyer’s change system. |
| Test method, laboratory, sampling, or acceptance criterion | Can change the meaning or comparability of release data. | Method comparison, validation, trend review and document revision. |
Drug owner, contract packer, distributor, and converter need different records
| Party | Decision it owns or supports | Record that prevents a gap |
|---|---|---|
| Drug product owner / market authorization holder | Intended use, suitability, regulatory strategy, stability, shelf life and post-change impact. | Approved container-closure description linked to stability batches and change control. |
| Contract packer | Line setup, sealing window, in-process controls, first-off release and deviation evidence. | Machine/tooling/material matrix and cavity-position records. |
| Foil converter or supplier | Controlled material manufacture, batch release, traceability, documents and notified changes. | Signed specification, batch CoA, roll map, retained sample and change notice. |
| Distributor or sourcing agent | Identity preservation, storage/transport, document flow and complaint traceability. | Unbroken lot/roll identity and a rule against substituting a catalog-equivalent material. |
Copyable RFQ and technical handoff record
Package: dosage form/project; cavity count and layout; lidding foil or strip pack; push-through, peelable, peel-push, tear/cut-open; forming-web structure and seal surface.
Material: requested layer order; OP/primer reference; print/ink route; aluminum alloy, temper, thickness and tolerances; HSL/VC reference and seal side; coating application fields; named methods and buyer criteria.
Print: artwork revision; colors; repeat; eye mark; registration; code/overprint zone; print side; winding diagram; approved proof; rub/set-off requirement.
Roll: width/tolerance; core ID/material; maximum OD or net weight/length; winding direction; edge/telescoping rule; splice count and marking; roll/pallet identification; storage and packing.
Line: machine and sealing station; tooling and seal land; current forming web; current approved foil; proposed speed range; available temperature/pressure/dwell data; current failure or change reason.
Evidence: specification; CoA fields; declarations/test reports; sample and trial quantity; sealing-window protocol; strength/integrity/opening methods; retained samples; change-notification requirements.
Open fields: mark every unknown as open. Do not fill a missing HSL, temperature, shelf life, regulatory status, or compatibility answer with a catalog assumption.
Decisions that still need project evidence
Do not use a web article to select the package for a drug, approve a supplier or site, set a universal seal temperature, define a universal seal-strength limit, establish child resistance, certify regulatory compliance, or assign shelf life. A listed test method also needs a program protocol and method assessment before it is applied to a particular blister geometry.
What you can take into a project is a working vocabulary that keeps lidding separate from forming, a reproducible specification, a trial record that keeps material and machine variables visible, and an evidence map that sends stability questions to the drug-product program.
Pharmaceutical blister lidding foil specifications: buyer questions
Does a CoA prove that blister lidding foil is suitable for my drug?
No. A CoA reports the fields and results listed for one material batch against an agreed specification. It does not prove finished-blister integrity, drug compatibility, patient opening, or shelf life. Suitability belongs to the complete container-closure system for the specific drug and intended use.
What sealing temperature should pharmaceutical blister lidding foil use?
No single sealing temperature applies to every blister line. The HSL must match the forming-web seal surface, and the observed seal depends on actual temperature, pressure, dwell, speed, tooling, seal land, tension, conditioning, and contamination. Establish a controlled window on the intended line and record actual readings.
Is high seal strength always better for a blister pack?
No. A minimum may support closure performance, while a peelable design may also need an upper limit for opening. The result must include specimen setup and failure mode. High sampled force can coexist with difficult opening, foil tearing, a local channel, or another whole-pack failure.
Is cold-form Alu-Alu foil the same as lidding foil?
No. Cold-form Alu-Alu is a multilayer forming web made into cavities. Lidding foil is the closing web sealed over those cavities. Both may contain aluminum, but their layer structures, thicknesses, processing, and evidence are different.
Does ISO 15378 certification approve the finished blister pack?
No. ISO 15378 is a quality-management and GMP framework for primary packaging-material suppliers. Finished-package suitability still depends on the exact components, manufacturing process, intended drug, validation, stability data, and market requirements. Supplier certification should also be verified before it is claimed.
Which lidding-foil changes should trigger reassessment?
Assess changes to alloy, temper, thickness, foil source or site, HSL, primer, OP, ink, coating application or cure, forming-web seal surface, artwork or eye mark, winding direction, machine or tooling, test method, sampling, and acceptance criteria. The depth of reassessment belongs to the approved change-control system.
Technical sources used
- FDA: Container Closure Systems for Packaging Human Drugs and Biologics
- 21 CFR 211.94: Drug product containers and closures
- ICH Q1A(R2): Stability Testing of New Drug Substances and Products
- WHO TRS 902 Annex 9: Guidelines on packaging for pharmaceutical products
- ISO 15378:2017 primary packaging materials for medicinal products
- ASTM F88/F88M-23: Seal strength of flexible barrier materials
- ASTM F3039-23: Dye penetration for nonporous packages
- ASTM F2096-11(2019): Gross leaks by internal pressurization
- Amcor: foil blister lidding constructions and opening routes
- ACG Alumlid: print-primer / aluminum / HSL structures
- ACG CR/SF foil: push-through, peelable, peel-push, and cut-open structures
- ACG blister packaging catalogue: line, sealing, feeding, and registration variables
- ISO 7271:2011 aluminum foil and thin strip dimensional tolerances
Prepare a lidding-foil review with Qixin
Qixin can begin a commercial review from the alloy and temper, thickness, width, print, HSL, roll format, trial-material quantity, and requested documents. Treat any public range as a discussion field until a project specification and evidence package are agreed.
For pharmaceutical blister lidding foil specifications, send the fields already approved by your quality and packaging teams and mark every unresolved field clearly. That keeps a supplier quotation separate from a package approval.
Send the opening route, forming-web seal surface, requested layer construction, alloy/temper/thickness target, roll width/core/winding, artwork and eye mark, machine and current sealing data, required documents, destination market, and the fields that are still open. Use the Qixin contact route to submit the technical file. Compatibility, process window, compliance, and shelf life remain subject to the buyer’s review and validation program.







